Alexander Titz

Alexander Titz

Auto-generated profile, based on publicly available information

Alexander Titz

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarbrücken, D-66123, Germany; Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-Braunschweig, Germany; Department of Chemistry, PharmaScienceHub (PSH), Saarland University, Saarbrücken, D-66123, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Nature Reviews Chemistry
Verified
Journal Article
Closed access
PDF file
MMMarcus Miethke
Marcus Miethke
MPMARCO PIERONI
MARCO PIERONI
TWTilmann Weber
Tilmann Weber
MBMark Brönstrup
Mark Brönstrup
PHPeter Hammann
Peter Hammann
RMRolf Müller
Rolf Müller

18 February 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SWStefanie Wagner
Stefanie Wagner
RSRoman Sommer
Roman Sommer
SHStefan Hinsberger
Stefan Hinsberger
CLCenbin Lu
Cenbin Lu
RHRolf W. Hartmann
Rolf W. Hartmann
ATAlexander Titz
Alexander Titz

20 December 2023 in npj Antimicrobials and Resistance
Verified
Journal Article
Open access
PDF file
DSDeepanshi Saxena
Deepanshi Saxena
RMRahul Maitra
Rahul Maitra
RBRakhi Bormon
Rakhi Bormon
MCMarta Czekanska
Marta Czekanska
JMJoscha Meiers
Joscha Meiers
SCSidharth Chopra
Sidharth Chopra
Emerging resistance to all available antibiotics highlights the need to develop new antibiotics with novel mechanisms of action. Most of the currently used antibiotics target Gram-positive bacteria while Gram-negative bacteria easily bypass the action of most drug molecules because of their unique outer membrane. This additional layer acts as a potent barrier restricting the entry of compounds into the cell. In this scenario, several approaches have been elucidated to increase the accumulation of compounds into Gram-negative bacteria. This review includes a brief description of the physicochemical properties that can aid compounds to enter and accumulate in Gram-negative bacteria and covers different strategies to target or bypass the outer membrane-mediated barrier in Gram-negative bacterial pathogens.

22 January 2018 in Journal of the American Chemical Society
Verified
Journal Article
Open access
RSRoman Sommer
Roman Sommer
SWStefanie Wagner
Stefanie Wagner
KRKatharina Rox
Katharina Rox
AVAnnabelle Varrot
Annabelle Varrot
DHDirk Hauck
Dirk Hauck
ATAlexander Titz
Alexander Titz
The opportunistic Gram-negative bacterium Pseudomonas aeruginosa is a leading pathogen for infections of immuno-compromised patients and those suffering from cystic fibrosis. Its ability to switch from planktonic life to aggregates, forming the so-called biofilms, is a front-line mechanism of antimicrobial resistance. The bacterial carbohydrate-binding protein LecB is an integral component and necessary for biofilm formation. Here, we report a new class of drug-like low molecular weight inhibitors of the lectin LecB with nanomolar affinities and excellent receptor binding kinetics and thermodynamics. This class of glycomimetic inhibitors efficiently blocked biofilm formation of P. aeruginosa in vitro while the natural monovalent carbohydrate ligands failed. Furthermore, excellent selectivity and pharmacokinetic properties were achieved. Notably, two compounds showed good oral bioavailability and high compound concentrations in plasma and urine were achieved in vivo.

26 May 2023 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
SLSteffen Leusmann
Steffen Leusmann
PMPetra Ménová
Petra Ménová
ESElena Shanin
Elena Shanin
ATAlexander Titz
Alexander Titz
CRChristoph Rademacher
Christoph Rademacher
Carbohydrates are essential mediators of many processes in health and disease. They regulate self-/non-self- discrimination, are key elements of cellular communication, cancer, infection and inflammation, and determine protein folding, function and life-times. Moreover, they are integral to the cellular envelope for microorganisms and participate in biofilm formation. These diverse functions of carbohydrates are mediated by carbohydrate-binding proteins, lectins, and the more the knowledge about the biology of these proteins is advancing, the more interfering with carbohydrate recognition becomes a viable option for the development of novel therapeutics. In this respect, small molecules mimicking this recognition process become more and more available either as tools for fostering our basic understanding of glycobiology or as therapeutics. In this review, we outline the general design principles of glycomimetic inhibitors (Section 2). This section is then followed by highlighting three approaches to interfere with lectin function, i.e. with carbohydrate-derived glycomimetics (Section 3.1), novel glycomimetic scaffolds (Section 3.2) and allosteric modulators (Section 3.3). We summarize recent advances in design and application of glycomimetics for various classes of lectins of mammalian, viral and bacterial origin. Besides highlighting design principles in general, we showcase defined cases in which glycomimetics have been advanced to clinical trials or marketed. Additionally, emerging applications of glycomimetics for targeted protein degradation and targeted delivery purposes are reviewed in Section 4.

8 January 2010 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ABAlex Butschi
Alex Butschi
ATAlexander Titz
Alexander Titz
MWMartin A Wälti
Martin A Wälti
VOVincent Olieric
Vincent Olieric
KPKatharina Paschinger
Katharina Paschinger
MKMarkus Künzler
Markus Künzler
The physiological role of fungal galectins has remained elusive. Here, we show that feeding of a mushroom galectin, Coprinopsis cinerea CGL2, to Caenorhabditis elegans inhibited development and reproduction and ultimately resulted in killing of this nematode. The lack of toxicity of a carbohydrate-binding defective CGL2 variant and the resistance of a C. elegans mutant defective in GDP-fucose biosynthesis suggested that CGL2-mediated nematotoxicity depends on the interaction between the galectin and a fucose-containing glycoconjugate. A screen for CGL2-resistant worm mutants identified this glycoconjugate as a Galβ1,4Fucα1,6 modification of C. elegans N-glycan cores. Analysis of N-glycan structures in wild type and CGL2-resistant nematodes confirmed this finding and allowed the identification of a novel putative glycosyltransferase required for the biosynthesis of this glycoepitope. The X-ray crystal structure of a complex between CGL2 and the Galβ1,4Fucα1,6GlcNAc trisaccharide at 1.5 Å resolution revealed the biophysical basis for this interaction. Our results suggest that fungal galectins play a role in the defense of fungi against predators by binding to specific glycoconjugates of these organisms. Fungi are a source of a large variety of carbohydrate-binding proteins (lectins). Synthesis of these proteins usually occurs in the cytoplasm and is often restricted to the reproductive organs (fruiting bodies, sclerotia) of the respective fungi. Although these lectins can be very abundant in these organs, their function is unknown. The specificity for non-fungal carbohydrates and recent functional studies in genetically amenable fungi argue against an endogenous function in development. Here we show that oral administration of the fruiting-body-specific galectins of the ink cap mushroom Coprinopsis cinerea is toxic for the model nematode Caenorhabditis elegans and that the nematotoxicity of these fungal lectins is dependent on binding to a specific β-galactoside occurring on nematode, but not on fungal, N-glycans. Since fungal-feeding nematodes represent the predominant predators of fungi in the soil, these results suggest that these lectins are effectors of a protein-mediated fungal defense system. Lectin-mediated defense strategies against predators, parasites and pathogens are also used by plants and animals. Due to the conservation of this type of innate defense amongst eukaryotes and the reduced complexity of fungi, studies of this in fungi could contribute to a better understanding of analogous systems and the evolution of multi-level defense in animals.